Nearly a year after BioTime Inc. started publicly sniffing around Geron Corp.'s stem cell assets, it landed its prize.
http://www.bizjournals.com/sanfrancisco/blog/biotech/2013/10/geron-grn-biotime-btx-stem-cells-spinal.html?ana=RSS&s=article_search&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+vertical_38+%28Health+Care+Regulation+Industry+News%29
http://www.bizjournals.com/sanfrancisco/blog/biotech/2013/10/geron-grn-biotime-btx-stem-cells-spinal.html?ana=RSS&s=article_search&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+vertical_38+%28Health+Care+Regulation+Industry+News%29
No comments:
Post a Comment